{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T14:15:51Z","timestamp":1784211351176,"version":"3.55.0"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,3]]},"abstract":"<jats:sec>\n            <jats:title>OBJECTIVE:<\/jats:title>\n            <jats:p>To identify maternal clinical risk factors for postcesarean maternal infection in a randomized clinical trial of preincision extended-spectrum antibiotic prophylaxis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS:<\/jats:title>\n            <jats:p>We conducted a planned secondary analysis of a randomized clinical trial. Patients were 24 weeks of gestation or greater and delivered by cesarean after a minimum of 4 hours of ruptured membranes or labor. All participants received standard preincision prophylaxis and were randomized to receive azithromycin or placebo. The primary outcome for this analysis is maternal infection: a composite outcome of endometritis, wound infection (superficial or deep), or other infections occurring up to 6 weeks postpartum. Maternal clinical characteristics associated with maternal infection, after controlling for azithromycin assignment, were identified. These maternal factors were included in a multivariable logistic regression model for maternal infection.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS:<\/jats:title>\n            <jats:p>Of 2,013 patients, 1,019 were randomized to azithromycin. Overall, 177 (8.8%) had postcesarean maternal infection. In the final adjusted model, compared with the reference groups, women of black race\u2013ethnicity, with a nontransverse uterine incision, with duration of membrane rupture greater than 6 hours, and surgery duration greater than 49 minutes, were associated higher odds of maternal infection (all with adjusted odds ratios [ORs] of approximately 2); azithromycin was associated with lower odds of maternal infection (adjusted OR 0.4, 95% confidence interval 0.3\u20130.6).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION:<\/jats:title>\n            <jats:p>Despite preincision azithromycin-based extended-spectrum antibiotic prophylaxis, postcesarean maternal infection remains a significant source of morbidity. Recognition of risk factors may help guide innovative prevention strategies.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CLINICAL TRIAL REGISTRATION:<\/jats:title>\n            <jats:p>ClinicalTrials.gov, https:\/\/clinicaltrials.gov, NCT012235546.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/aog.0000000000001899","type":"journal-article","created":{"date-parts":[[2017,2,23]],"date-time":"2017-02-23T06:47:16Z","timestamp":1487832436000},"page":"481-485","source":"Crossref","is-referenced-by-count":35,"title":["Risk Factors for Postcesarean Maternal Infection in a Trial of Extended-Spectrum Antibiotic Prophylaxis"],"prefix":"10.1097","volume":"129","author":[{"given":"Kim A.","family":"Boggess","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Tita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Jauk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Saade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherri","family":"Longo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin A. S.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Esplin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Cleary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Wapner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelli","family":"Letson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Owens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Blackwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Beamon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey M.","family":"Szychowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Cesarean Section Optimal Antibiotic Prophylaxis Trial Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230711","first-page":"1","article-title":"National Hospital Discharge Survey: 2005 annual summary with detailed diagnosis and procedure data","author":"DeFrances","year":"2007","journal-title":"Vital Health Stat 13"},{"issue":"suppl","key":"R2-20230711","doi-asserted-by":"crossref","first-page":"178S","DOI":"10.1097\/00006250-198003001-00045","article-title":"Clinical risk factors for puerperal infection","volume":"55","author":"Gibbs","year":"1980","journal-title":"Obstet Gynecol"},{"key":"R3-20230711","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1067\/mob.2001.111303","article-title":"Prophylactic use of antibiotics for nonlaboring patients undergoing cesarean delivery with intact membranes: a meta-analysis","volume":"184","author":"Chelmow","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"R4-20230711","doi-asserted-by":"crossref","first-page":"301.e1","DOI":"10.1016\/j.ajog.2008.06.077","article-title":"Timing of perioperative antibiotics for cesarean delivery: a metaanalysis","volume":"199","author":"Costantine","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"R5-20230711","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/AOG.0b013e318197c3b6","article-title":"Emerging concepts in antibiotic prophylaxis for cesarean delivery: a systematic review","volume":"113","author":"Tita","year":"2009","journal-title":"Obstet Gynecol"},{"key":"R6-20230711","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1056\/NEJMoa1602044","article-title":"Adjunctive azithromycin prophylaxis for cesarean delivery","volume":"375","author":"Tita","year":"2016","journal-title":"N Engl J Med"},{"issue":"suppl 2","key":"R7-20230711","first-page":"51S","article-title":"Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults\u2014the evidence report. National Institutes of Health","volume":"6","year":"1998","journal-title":"Obes Res"},{"key":"R8-20230711","article-title":"Obesity: preventing and managing the global epidemic. Report of a WHO consultation","volume":"894","year":"2000","journal-title":"World Health Organ Tech Rep Ser"},{"key":"R9-20230711","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.bjid.2014.09.009","article-title":"Risk factors for surgical site infection following cesarean section in a Brazilian Women's Hospital: a case-control study","volume":"19","author":"Farret","year":"2015","journal-title":"Braz J Infect Dis"},{"key":"R10-20230711","doi-asserted-by":"crossref","first-page":"700.e1","DOI":"10.1016\/j.ajog.2008.03.031","article-title":"Length of rupture of membranes in the setting of premature rupture of membranes at term and infectious maternal morbidity","volume":"198","author":"Tran","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"R11-20230711","first-page":"32","article-title":"Post-caesarean section surgical site infection: rate and risk factors","volume":"124","author":"Ghuman","year":"2011","journal-title":"N Z Med J"},{"key":"R12-20230711","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1086\/587810","article-title":"Risk factors for surgical site infection after low transverse cesarean section","volume":"29","author":"Olsen","year":"2008","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R13-20230711","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1111\/j.1471-0528.2012.03452.x","article-title":"Risk factors for surgical site infection following caesarean section in England: results from a multicentre cohort study","volume":"119","author":"Wloch","year":"2012","journal-title":"BJOG"},{"key":"R14-20230711","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3109\/00016340903568175","article-title":"Wound length and corticosteroid administration as risk factors for surgical-site complications following cesarean section","volume":"89","author":"De Vivo","year":"2010","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R15-20230711","first-page":"131","article-title":"Uterine incision and maternal morbidity after cesarean section for delivery of the very low birthweight fetus","volume":"169","author":"Druzin","year":"1989","journal-title":"Surg Gynecol Obstet"},{"key":"R16-20230711","first-page":"633","article-title":"Maternal and perinatal morbidity associated with classic and inverted T cesarean incisions","volume":"100","author":"Patterson","year":"2002","journal-title":"Obstet Gynecol"},{"key":"R17-20230711","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1097\/AOG.0b013e3181a6d011","article-title":"Antibiotic prophylaxis for gynecologic procedures. ACOG Practice Bulletin No. 104. American College of Obstetricians and Gynecologists","volume":"113","year":"2009","journal-title":"Obstet Gynecol"},{"key":"R18-20230711","doi-asserted-by":"crossref","first-page":"182","DOI":"10.2307\/30145558","article-title":"Quality standard for antimicrobial prophylaxis in surgical procedures. The Infectious Diseases Society of America","volume":"15","author":"Dellinger","year":"1994","journal-title":"Infect Control Hosp Epidemiol"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006250-201703000-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T14:07:21Z","timestamp":1689084441000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006250-201703000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000001899","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]}}}